These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34827247)

  • 21. Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran.
    Alaei N; Aziemzadeh M; Bahador A
    J Glob Antimicrob Resist; 2016 Jun; 5():75-9. PubMed ID: 27436472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbapenem-resistant Acinetobacter baumannii isolates carrying bla
    Yazdansetad S; Najari E; Ghaemi EA; Javid N; Hashemi A; Ardebili A
    J Glob Antimicrob Resist; 2019 Sep; 18():95-99. PubMed ID: 30763760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal.
    Gijón D; García-Castillo J; Fernández-López MC; Bou G; Siller M; Calvo-Montes J; Pitart C; Vila J; Torno N; Gimeno C; Cruz H; Ramos H; Mulet X; Oliver A; Ruiz-Garbajosa P; Canton R
    Rev Esp Quimioter; 2024 Feb; 37(1):69-77. PubMed ID: 37882320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains.
    Padovani M; Bertelli A; Corbellini S; Piccinelli G; Gurrieri F; De Francesco MA
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107147
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant
    Seifert H; Müller C; Stefanik D; Higgins PG; Wohlfarth E; Kresken M
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508268
    [No Abstract]   [Full Text] [Related]  

  • 27. In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
    Golden AR; Adam HJ; Baxter M; Walkty A; Lagacé-Wiens P; Karlowsky JA; Zhanel GG
    Diagn Microbiol Infect Dis; 2020 May; 97(1):115012. PubMed ID: 32081522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.
    Oueslati S; Bogaerts P; Dortet L; Bernabeu S; Ben Lakhal H; Longshaw C; Glupczynski Y; Naas T
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019).
    Takemura M; Wise MG; Hackel MA; Sahm DF; Yamano Y
    J Antimicrob Chemother; 2023 Aug; 78(8):2019-2027. PubMed ID: 37390312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens.
    Dobias J; Dénervaud-Tendon V; Poirel L; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2319-2327. PubMed ID: 28748397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014-2018 studies in Spain.
    Cercenado E; Cardenoso L; Penin R; Longshaw C; Henriksen AS; Pascual A
    J Glob Antimicrob Resist; 2021 Sep; 26():292-300. PubMed ID: 34274538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against
    Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F
    Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Naas T; Lina G; Santerre Henriksen A; Longshaw C; Jehl F
    JAC Antimicrob Resist; 2021 Jun; 3(2):dlab081. PubMed ID: 34223140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
    Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
    J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria.
    Dortet L; Niccolai C; Pfennigwerth N; Frisch S; Gonzalez C; Antonelli A; Giani T; Hoenings R; Gatermann S; Rossolini GM; Naas T
    J Antimicrob Chemother; 2023 Jul; 78(7):1672-1676. PubMed ID: 37209112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.
    Bonnin RA; Emeraud C; Jousset AB; Naas T; Dortet L
    Clin Microbiol Infect; 2022 Aug; 28(8):1156.e1-1156.e5. PubMed ID: 35533970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Oxacillinase and Metallo-β-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran.
    Shoja S; Moosavian M; Rostami S; Abbasi F; Tabatabaiefar MA; Peymani A
    Jundishapur J Microbiol; 2016 May; 9(5):e32388. PubMed ID: 27540456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
    Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Diversity of OXA-like Genes in Multidrug-Resistant Acinetobacter baumannii Strains from ICUs.
    Guclu AU; Gozen AG
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Bacilli by Broth Microdilution and Disk Diffusion Method: A Single-Center Study in Odisha, India.
    Nayak G; Behera B; Mohanty S; Kar P; Jena J
    Infect Drug Resist; 2022; 15():5887-5897. PubMed ID: 36237292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.